Abstract
References
Articles referenced by this article (73)
The Blood and Bone Marrow in Yelloe Cross Gas (Mustard Gas) Poisoning: Changes produced in the Bone Marrow of Fatal Cases.
J Med Res, (3):497-508.3 1919
MED: 19972497
Experimental and clinical studies on the treatment of cancer by dichloroethylsulphide (mustard gas)
Annals of Surgery 1931
The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides.
Science, (2675):409-436 1946
MED: 17751251
Cyto-active amino-acid and peptide derivatives: Part 1. Substituted phenylalanines
Journal of the Chemical Society 1954
Pharmacological characterisation of cyclophosphamide (NSC 26 271) and cyclophosphamide metabolites
Cancer Chemotherapy Reports 1967
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2.
J Med Chem, (2):677-681 1990
MED: 2299634
Myleran in chronic myeloid leukaemia; results of treatment.
Lancet, (6753):208-213 1953
MED: 13097987
Potential anticancer agents. XXXI. The relationship of chemical structure to antileukaemic activity with analogues of 1-methyl-3-nitro-1-nitrosoguanidine (NSC-9369).
J Med Pharm Chem, 299-333 1960
MED: 13831483
The mechanism of the cytotoxic action of alkylating agents in mammalian cells
1968
Show 10 more references (10 of 73)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1016/0268-960x(92)90028-o
Article citations
Alkylating agents-induced gonadotoxicity in prepubertal males: Insights on the clinical and preclinical front.
Clin Transl Sci, 17(7):e13866, 01 Jul 2024
Cited by: 1 article | PMID: 38965809 | PMCID: PMC11224131
Review Free full text in Europe PMC
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.
Int J Hematol, 119(4):450-458, 25 Jan 2024
Cited by: 0 articles | PMID: 38267673
Infections in Patients with Systemic Lupus Erythematosus: The Contribution of Primary Immune Defects Versus Treatment-Induced Immunosuppression.
Eur J Rheumatol, 10(4):148-158, 01 Oct 2023
Cited by: 0 articles | PMID: 37850609 | PMCID: PMC10765185
Review Free full text in Europe PMC
The Current Status of DNA-Repair-Directed Precision Oncology Strategies in Epithelial Ovarian Cancers.
Int J Mol Sci, 24(8):7293, 14 Apr 2023
Cited by: 6 articles | PMID: 37108451 | PMCID: PMC10138422
Review Free full text in Europe PMC
Aging microenvironment and antitumor immunity for geriatric oncology: the landscape and future implications.
J Hematol Oncol, 16(1):28, 21 Mar 2023
Cited by: 9 articles | PMID: 36945046 | PMCID: PMC10032017
Review Free full text in Europe PMC
Go to all (83) article citations
Other citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Alkylating Agents, the Road Less Traversed, Changing Anticancer Therapy.
Anticancer Agents Med Chem, 22(8):1478-1495, 01 Jan 2022
Cited by: 7 articles | PMID: 34382529
Review
O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance.
Hematol Oncol Clin North Am, 9(2):431-450, 01 Apr 1995
Cited by: 25 articles | PMID: 7642472
Review
Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Cancer Res, 49(22):6185-6192, 01 Nov 1989
Cited by: 59 articles | PMID: 2804968
Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence.
Cancer Chemother Pharmacol, 45(3):239-246, 01 Jan 2000
Cited by: 2 articles | PMID: 10663642